npj Vaccines (Sep 2024)

Low-frequency CD8+ T cells induced by SIGN-R1+ macrophage-targeted vaccine confer SARS-CoV-2 clearance in mice

  • Daisuke Muraoka,
  • Meng Ling Moi,
  • Osamu Muto,
  • Takaaki Nakatsukasa,
  • Situo Deng,
  • Chieko Takashima,
  • Rui Yamaguchi,
  • Shin-ichi Sawada,
  • Haruka Hayakawa,
  • Thi Thanh Ngan Nguyen,
  • Yasunari Haseda,
  • Takatoshi Soga,
  • Hirokazu Matsushita,
  • Hiroaki Ikeda,
  • Kazunari Akiyoshi,
  • Naozumi Harada

DOI
https://doi.org/10.1038/s41541-024-00961-6
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 17

Abstract

Read online

Abstract Vaccine-induced T cells and neutralizing antibodies are essential for protection against SARS-CoV-2. Previously, we demonstrated that an antigen delivery system, pullulan nanogel (PNG), delivers vaccine antigen to lymph node medullary macrophages and thereby enhances the induction of specific CD8+ T cells. In this study, we revealed that medullary macrophage-selective delivery by PNG depends on its binding to a C-type lectin SIGN-R1. In a K18-hACE2 mouse model of SARS-CoV-2 infection, vaccination with a PNG-encapsulated receptor-binding domain of spike protein decreased the viral load and prolonged the survival in the CD8+ T cell- and B cell-dependent manners. T cell receptor repertoire analysis revealed that although the vaccine induced T cells at various frequencies, low-frequency specific T cells mainly promoted virus clearance. Thus, the induction of specific CD8+ T cells that respond quickly to viral infection, even at low frequencies, is important for vaccine efficacy and can be achieved by SIGN-R1+ medullary macrophage-targeted antigen delivery.